Second‐line chemotherapy for locally advanced or metastatic small cell lung cancer
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The objective of this systematic review is to explore the benefits of second‐line chemotherapy in patients with resistant (a relapse within three months of first treatment) or relapsed (a relapse after three months of first treatment) SCLC.